Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1617-2024Class II

Biomet OrthoPak Non-invasive Bone Growth Stimulator System-Indicated for the treatment of an established...

Ebi, LLC / initiated 2024-03-22 / Open, Classified / root cause: design

EBI, LLC began a recall of Biomet OrthoPak Non-invasive Bone Growth Stimulator System-Indicated for the treatment of an established nonunion acquired secondary to trauma, excluding... on . FDA classified it as Class II and gives the reason as "Damage to the lead wire sheath (black cable) component and causing exposure of the wires, potentially lead to no therapeutic treatment signal being delivered to the electrodes, and result in delay of treatment". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-1617-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Ebi, LLC
Product
Biomet OrthoPak Non-invasive Bone Growth Stimulator System-Indicated for the treatment of an established nonunion acquired secondary to trauma, excluding vertebrae and all flat bones. Part Number: 1067718
Product code
LOF Stimulator, Bone Growth, Non-Invasive
Reason for recall
Damage to the lead wire sheath (black cable) component and causing exposure of the wires, potentially lead to no therapeutic treatment signal being delivered to the electrodes, and result in delay of treatment
Root cause tag
design
FDA root cause
Device Design
Action
ZimVie issued Urgent Medical Device Correction letter to Patients, Physicians, Sales Representatives on 3/22/24 . Letter states reason for recall, health risk and action to take: 1. Review this notification for awareness of the contents. 2. Before each use, inspect your device s lead wires (black cable) for damage. If found to be damaged, contact Customer Service at 1-800-526-2579 x 6000 for a complimentary replacement. 3. Complete the Acknowledgement and Receipt Form either by scanning the QR code on the postcard included with this letter and completing the online form or mailing back the completed postcard. To complete your Acknowledgement, you will need to include your Unique Patient Reference Number included on the top of the first page of this letter. This acknowledgement should be completed even if you do not have affected product. 4. If you have further questions or concerns after reviewing this notice, please call customer service at 1-800-526-2579 x 6000. Customer Service Representatives are available from 8:30 am to 5:00 pm (EST), Monday through Friday. At other times, please leave a clear message for a return call by the next business day. Alternatively, your questions may be emailed to [email protected].
Quantity in commerce
1412 units ( 2 leads per assembly)
Distribution
US Nationwide distribution.
Product codes and lots
UD-DI: 00812301020232 All devices distributed since May 1, 2023

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1617-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1616-2024Class IIOngoingVoluntary: Firm initiated
Z-1617-2024Class IIOngoingVoluntary: Firm initiated
Z-1618-2024Class IIOngoingVoluntary: Firm initiated
Z-1619-2024Class IIOngoingVoluntary: Firm initiated